GPT and type 2 diabetes mellitus: HucMDEs not only improved insulin resistance and increased insulin sensitivity in T2DM rats but also relieved liver dysfunction and improve lipid profiles, as evidenced by significantly decreased serum levels of ALT, AST, TC, and TG.